Nexgel, Inc. (NXGL) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Nexgel reported revenue of $11.4M, up 31.5% from $8.7M the year before. Net income was -$3.0M (a -26.3% net margin), or -$7.60 per diluted share. Gross margin was 39.5% and operating margin was -29.3%. Operating activities generated -$1.3M of cash, leaving -$1.4M of free cash flow. At fiscal year end, Nexgel held $10.5M in total assets against $5.6M in total liabilities.
Open the full interactive Nexgel financials → Quarterly statements, key ratios, valuation history and price charts.
Nexgel Key Stats
| Share Price | $4.05 |
|---|---|
| Market Cap | $1.8M |
| Revenue YoY Growth | +31.5% |
| 52-Week Range | $0.29 – $5.62 |
| Shares Outstanding | 450,663 (basic, 2026 Q2) |
Nexgel Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $674,000 | $1.6M | $2.0M | $4.1M | $8.7M | $11.4M |
| Gross Profit | -$291,000 | $9,000 | $256,000 | $619,000 | $2.7M | $4.5M |
| Operating Income | -$2.3M | -$2.6M | -$3.3M | -$3.5M | -$3.6M | -$3.4M |
| Pre-Tax Income | -$2.3M | -$4.3M | -$4.7M | -$3.2M | -$3.5M | -$2.9M |
| Income Tax | $0 | $0 | $0 | -$31,000 | -$182,000 | $107,000 |
| Net Income | -$2.3M | -$4.3M | -$4.7M | -$3.2M | -$3.3M | -$3.0M |
| Diluted EPS | -$0.60 | -$29.00 | — | -$11.20 | -$10.00 | -$7.60 |
Nexgel Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.9M | $2.8M | $2.6M | $3.7M |
| Net Income | -$653,000 | -$970,000 | -$927,000 | -$3.6M |
| Diluted EPS | -$1.60 | -$0.12 | -$2.20 | -$8.00 |
Nexgel Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $32,000 | $13.3M | — | — | — | — |
| Current Assets | $363,000 | $13.9M | $7.5M | $5.1M | $5.1M | $4.3M |
| Total Assets | $2.3M | $17.0M | $10.4M | $10.0M | $11.0M | $10.5M |
| Current Liabilities | $1.3M | $2.9M | $859,000 | $2.5M | $2.5M | $3.0M |
| Total Long-Term Debt | — | $1.4M | $283,000 | $593,000 | $685,000 | $588,000 |
| Total Liabilities | $2.2M | $4.9M | $2.7M | $4.8M | $4.9M | $5.6M |
| Shareholders' Equity | $71,000 | $12.1M | $7.6M | $4.7M | $5.8M | $4.5M |
Nexgel Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$1.8M | -$2.8M | -$3.0M | -$3.2M | -$3.9M | -$1.3M |
| Cash From Investing | -$312,000 | -$269,000 | -$5.6M | $4.5M | -$775,000 | -$68,000 |
| Cash From Financing | $1.9M | $16.3M | -$3.7M | $379,000 | $3.7M | $630,000 |
| Free Cash Flow | -$2.1M | -$3.0M | -$3.1M | -$3.9M | -$4.3M | -$1.4M |
Figures from Nexgel's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Nexgel financials page for every line item.
Nexgel Company Profile
| Ticker | NXGL |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Langhorne, Pennsylvania |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001468929 |
Frequently Asked Questions
What was Nexgel's revenue in fiscal 2025?
Nexgel (NXGL) reported revenue of $11.4M for fiscal 2025.
What is Nexgel's annual revenue history?
Nexgel's annual revenue by fiscal year: 2020: $674,000; 2021: $1.6M; 2022: $2.0M; 2023: $4.1M; 2024: $8.7M; 2025: $11.4M.
What was Nexgel's net income in fiscal 2025?
Nexgel reported net income of -$3.0M for fiscal 2025.
What was Nexgel's earnings per share (EPS) in fiscal 2025?
Nexgel's diluted EPS was -$7.60 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Nexgel generate in fiscal 2025?
Nexgel generated -$1.4M of free cash flow in fiscal 2025.
What was Nexgel's revenue last quarter?
In its most recent reported quarter (2026 Q2), Nexgel reported revenue of $3.7M.
How much debt does Nexgel have?
Nexgel reported $588,000 of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Nexgel are outstanding?
Nexgel reported a weighted average of 450,663 basic shares outstanding in 2026 Q2.
What is Nexgel's market cap?
Based on its latest closing price, Nexgel (NXGL) has a market capitalization of about $1.8M.
When does Nexgel's fiscal year end?
Nexgel's fiscal year end, as registered with the SEC, is December 31.
Where is Nexgel headquartered?
Nexgel lists its business address in Langhorne, Pennsylvania in its SEC filings.
Nexgel Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →